AQP3 and prostate carcinoma: Chen et al. (2015) showed that AQP3 silencing by small interfering RNA (siRNA) inhibited motility and invasiveness in prostate cancer cells through a reduction in extracellular signal-regulated kinase (ERK) 1⁄2 activation [80].